Sidney A. Cohen

发表

Refining calcium test for diagnosis of medullary thyroid cancer: cutoffs, procedures and safety

Deepak L. Bhatt, R. D'Agostino, S. Oparil, 2014, The New England journal of medicine.

Effect of Catheter-Based Renal Denervation on Morning and Nocturnal Blood Pressure: Insights From SYMPLICITY HTN-3 and SYMPLICITY HTN-Japan.

Deepak L. Bhatt, K. Kario, G. Bakris, 2015, Hypertension.

Sympathetic Response and Outcomes Following Renal Denervation in Patients With Chronic Heart Failure: 12-Month Outcomes From the Symplicity HF Feasibility Study.

C. Hayward, H. Krum, T. Marwick, 2017, Journal of cardiac failure.

Impact of renal denervation on 24-hour ambulatory blood pressure: results from SYMPLICITY HTN-3.

Deepak L. Bhatt, R. D'Agostino, S. Oparil, 2014, Journal of the American College of Cardiology.

Changes in Plasma Renin Activity after Renal Artery Sympathetic Denervation.

S. Pocock, K. Kario, M. Böhm, 2021, Journal of the American College of Cardiology.

Outcomes of unselected recipients of sirolimus-eluting stents: the Cypher stent U.S. post-marketing surveillance registry.

P. Block, P. Berger, E. Perin, 2010, The Journal of invasive cardiology.

Frequency and impact of bleeding in elective coronary stent clinical trials—Utility of three commonly used definitions

V. Novack, L. Novack, D. Cutlip, 2012, Catheterization and cardiovascular interventions.

Twenty-Four-Hour Ambulatory Blood Pressure Reduction Patterns After Renal Denervation in the SPYRAL HTN-OFF MED Trial.

Manesh R. Patel, K. Kario, M. Böhm, 2018, Circulation.

Renal Denervation in High-Risk Patients With Hypertension.

R. Whitbourn, G. Mancia, L. Ruilope, 2020, Journal of the American College of Cardiology.

12-month blood pressure results of catheter-based renal artery denervation for resistant hypertension: the SYMPLICITY HTN-3 trial.

Deepak L. Bhatt, R. D'Agostino, S. Oparil, 2015, Journal of the American College of Cardiology.

Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial

Manesh R. Patel, Neha J. Pagidipati, J. Stehli, 2020, The Lancet.

Effect of coronary target lesion revascularization on late cardiac events after insertion of sirolimus-eluting or bare metal stents.

M. Pencina, V. Novack, J. Moses, 2010, The American journal of cardiology.

PROOF trial: protection from pulmonary embolism with the OptEase filter.

J. Duncan, Sidney A. Cohen, J. Ziegler, 2008, Journal of vascular and interventional radiology : JVIR.

The Jonas study: evaluation of the retrievability of the Cordis OptEase inferior vena cava filter.

G. Soulez, M. Giroux, Sidney A. Cohen, 2005, Journal of vascular and interventional radiology : JVIR.

Prioritized Endpoints for Device-Based Hypertension Trials: the Win Ratio Methodology.

S. Pocock, M. Böhm, M. Fahy, 2020, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 Trial

Manesh R. Patel, Timothy N Murphy, Deepak L. Bhatt, 2022, The Lancet.

OptEase Retrievable Inferior Vena Cava Filter: Initial Multicenter Experience

D. Rosenthal, E. Wellons, Sidney A. Cohen, 2005, Vascular.

Impact of Stroke Volume Index and Left Ventricular Ejection Fraction on Mortality After Aortic Valve Replacement.

D. Adams, G. Deeb, J. Oh, 2020, Mayo Clinic proceedings.

Five-year follow-up of the Sirolimus-Eluting Stents vs Vascular Brachytherapy for Bare Metal In-Stent Restenosis (SISR) trial.

P. Teirstein, L. Mauri, L. Satler, 2012, American heart journal.

Five-year follow up after sirolimus-eluting stent implantation results of the SIRIUS (Sirolimus-Eluting Stent in De-Novo Native Coronary Lesions) Trial

Hong Wang, Giora Weisz, Jeffrey W Moses, 2009 .

Potential future clinical applications for the GPIIb/IIIa antagonist, abciximab in thrombosis, vascular and oncological indications

M. Mascelli, M. Trikha, Sidney A. Cohen, 2009, Pathology & Oncology Research.

Structure, function and expression of voltage-dependent sodium channels

R. Kallen, Sidney A. Cohen, R. Barchi, 2007, Molecular Neurobiology.

Evaluation of the time saved by prehospital initiation of reteplase for ST-elevation myocardial infarction: results of The Early Retavase-Thrombolysis in Myocardial Infarction (ER-TIMI) 19 trial.

E. Antman, R. Giugliano, E. Braunwald, 2002, Journal of the American College of Cardiology.

Localization of epitopes for antibodies that differentially label sodium channels in skeletal muscle surface and T-tubular membranes

Sidney A. Cohen, R. Barchi, 1992, The Journal of Membrane Biology.

Voltage-gated sodium channel (SkM1) content in dystrophin-deficient muscle

P. Ribaux, Sidney A. Cohen, C. Berthier, 2001, Pflügers Archiv.

A randomized comparison of sirolimus‐eluting versus bare metal stents in the treatment of diabetic patients with native coronary artery lesions: The DECODE study

M. Buchbinder, U. Kaul, Sidney A. Cohen, 2008, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial

Neil Chapman, Michael Böhm, Kazuomi Kario, 2017, The Lancet.

The SPYRAL HTN Global Clinical Trial Program: Rationale and design for studies of renal denervation in the absence (SPYRAL HTN OFF-MED) and presence (SPYRAL HTN ON-MED) of antihypertensive medications.

S. Pocock, K. Kario, M. Böhm, 2016, American heart journal.

Clot lysis in a primate model of peripheral arterial occlusive disease with use of systemic or intraarterial reteplase: addition of abciximab results in improved vessel reperfusion.

R. Jordan, J. Guerrero, M. Nedelman, 2004, Journal of vascular and interventional radiology : JVIR.

Safety and efficacy of the 2.25-mm sirolimus-eluting Bx Velocity stent in the treatment of patients with de novo native coronary artery lesions: the SIRIUS 2.25 trial.

Hong Wang, Eugenia Nikolsky, Roxana Mehran, 2006, The American journal of cardiology.

Intravascular Ultrasound Results From the NEVO ResElution-I Trial: A Randomized, Blinded Comparison of Sirolimus-Eluting NEVO Stents With Paclitaxel-Eluting Taxus Liberté Stents in De Novo Native Coronary Artery Lesions

P. Fitzgerald, C. Rogers, J. Popma, 2011, Circulation. Cardiovascular interventions.

3-year follow-up of the SISR (Sirolimus-Eluting Stents Versus Vascular Brachytherapy for In-Stent Restenosis) trial.

P. Teirstein, L. Mauri, L. Satler, 2008, JACC. Cardiovascular interventions.

Sirolimus-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the SISR randomized trial.

P. Teirstein, P. Fitzgerald, L. Satler, 2006, JAMA.

Long-term results of carotid stenting versus endarterectomy in high-risk patients.

Hong Wang, T. Bajwa, J. Massaro, 2008, The New England journal of medicine.

Imaging strategies for safety surveillance after renal artery denervation

R. Townsend, J. Popma, S. Uretsky, 2021, Clinical Research in Cardiology.

Carotid artery stenting with emboli protection surveillance study: Thirty‐day results of the CASES‐PMS study

L. Mauri, B. Katzen, Sidney A. Cohen, 2007, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial

S. Pocock, N. Chapman, K. Kario, 2018, The Lancet.

A qualitative and quantitative angiographic analysis of stent fracture late following sirolimus-eluting stent implantation.

M. Leon, D. Kandzari, J. Popma, 2009, The American journal of cardiology.

Effect of renal denervation in attenuating the stress of morning surge in blood pressure: post-hoc analysis from the SPYRAL HTN-ON MED trial

K. Kario, M. Böhm, R. Townsend, 2020, Clinical Research in Cardiology.

Sodium Channel Distribution Within the Rabbit Atrioventricular Node as Analysed by Confocal Microscopy

A Shrier, A. Shrier, D. Laird, 1997, The Journal of physiology.

Utility of sirolimus-eluting Cypher stents to reduce 12-month target vessel revascularization in saphenous vein graft stenoses: results of a multicenter 350-patient case-control study.

S. Ellis, Marilyn Borgman, F. Resnic, 2007, The Journal of invasive cardiology.

Cost analysis of four major drug-eluting stents in diabetic populations.

Sidney A. Cohen, David Banko, N. Ferko, 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Impact of target lesion and nontarget lesion cardiac events on 5-year clinical outcomes after sirolimus-eluting or bare-metal stenting.

V. Novack, J. Moses, M. Leon, 2009, JACC. Cardiovascular interventions.

The GENESIS (Randomized, Multicenter Study of the Pimecrolimus-Eluting and Pimecrolimus/Paclitaxel-Eluting Coronary Stent System in Patients with De Novo Lesions of the Native Coronary Arteries) trial.

Pierfrancesco Agostoni, Alexandra J Lansky, P. Fitzgerald, 2009, JACC. Cardiovascular interventions.

The SIRIUS‐DIRECT trial: A multi‐center study of direct stenting using the sirolimus‐eluting stent in patients with de novo native coronary artery lesions

P. Fitzgerald, J. Moses, M. Leon, 2007, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

NEVO™: a new generation of sirolimus-eluting coronary stent.

C. Rogers, R. Falotico, Sidney A. Cohen, 2009, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Evaluation of the time saved byprehospital initiation of reteplase forST-elevation myocardial infarction

E. Antman, R. Giugliano, E. Braunwald, 2002 .

Five-year follow-up after sirolimus-eluting stent implantation results of the SIRIUS (Sirolimus-Eluting Stent in De-Novo Native Coronary Lesions) Trial.

P. Teirstein, Hong Wang, J. Moses, 2009, Journal of the American College of Cardiology.

Two-year intravascular ultrasound observations in diabetic patients treated with single and double dose sirolimus-eluting stents: results of the double dose diabetes (3D) study.

B. Lewis, P. Fitzgerald, Y. Shimada, 2008, The Journal of invasive cardiology.

CORONARY ARTERY DISEASE Original Studies A Randomized Comparison of Sirolimus-Eluting Versus Bare Metal Stents in the Treatment of Diabetic Patients with Native Coronary Artery Lesions: The DECODE Study

M. Buchbinder, Sidney A. Cohen, R. Zambahari, 2008 .

Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial

S. Pocock, N. Chapman, K. Kario, 2018, The Lancet.